Open Enrollement Studies - Escondido
Depression-MDDM-FAges 18-65 No BMI 54 Weeks 20 Visits |
Treatment resistant Current depressive episode must be greater than 8 weeks No more than 1 antidepressant for current episode |
Depression-MDDM-FAges 18-65 No BMI 18 Weeks 14 Visits |
Treatment resistant Current depressive episode must be greater than 8 weeks No more than 1 antidepressant for current episode |
Depression – MDDM-FAges 18-55 No BMI 13-15 Weeks 13 Visits |
Treatment Resistant No more that 3 antidepressants for current episode |
Depression-MDDM-FAges 18-65 BMI 18-40 8 Weeks 8 Visits |
No use of antidepressants within 2 weeks of Visit 1 Current episode must be at least 8 weeks No history of treatment resistance to more than 2 antidepressants |
Adolescent DepressionM-FAges 7-11 44 lbs at least 40 Weeks 16 Visits |
No history of treatment resistance to more than 2 antidepressants Reliable parent or guardian to accompany on visits No 1st degree relatives with bipolar disorder . |
Diabetes MellitusM-FAges18+ BMI 45 or less 24 Weeks 8 Visits |
Must be taking Actos and Metformin At least 1500 mg per day of Metformin |
Diabetes MellitusM-FAges 18+ BMI 45 or less 52 Weeks 12 Visits |
Must be taking basal insulin alone or in combination with Metformin and/or Pioglitazone. |
Diabetic NeuropathyM-FAges 18+ BMI 45 or less 113 Days 15 Visits |
Diabetes Type 1 or 2 Must be taking analgesic medication for at least 2 months before Visit 1 |
Chronic Lower Back PainM-FAges 18+ No BMI 24 Weeks 12 Visits |
Unchanged regimen of analgesic medication for back pain taken daily for at least 3 months before Visit 1 No involvement in an active workman’s comp claim, disability claim or active litigation related to back pain |
Epilepsy InpatientM-FAges 18-65 29 Days with 4 Inpatient days |
Partial onset or primary generalized seizures and receiving a stable dose of TPM IR No history of generalized status epilepticus within 2 years |
EpilepsyM-FAges 16-70 No BMI 19 weeks 10 visits |
Diagnosis of partial epilepsy Documented CT or MRI scan conducted within 5 years prior to study entry At least 4 partial onset seizures during the 8 weeks prior to study entry |
Schizophrenia/ SchizoaffectiveM-FAges 18+ BMI 18-40 42 Days 8 Visits |
Clinically stable Treatment with a maximum of 2 antipsychotic |
SchizophreniaM-FAges 18-60 No BMI 28 weeks 23 visits |
Shown previous response to an antipsychotic in the past year other than Clozapine Currently being treated with an antipsychotic and willing to be treated with intramuscular injection for study duration History of exacerbation when not taking antipsychotics |
Schizophrenia InpatientM-FAges 18-65 No BMI 3 weeks inpatient 5 year extension study |
Diagnosis of Schizophrenia for at least 2 years prior to study entry At least 1 illness exacerbation within 2 weeks prior to study entry requiring an intensification of psychiatric care No continuous treatment of risperidone greater than 72 hours within 2 weeks of study entry |
SchizophreniaInpatientM-F Ages 18-65 No BMI 17 Weeks 2 Weeks inpatient |
Receiving monotherapy treatment for at least 3 months prior to study entry with either aripiprazole, olanzapine, risperidone or quetiapine and on a fixed dose |
SchizophreniaInpatientM-F Ages 18-65 BMI 18-40 36 days inpatient |
Documentation of exacerbation within 4 weeks of study entry No hospitalization within 2 weeks of study entry |
SchizophreniaM-FAges 18-65 No BMI 15 months 18 visits |
Must be on 1 oral antipsychotic prior to study entry Must have had at least 2 arrests with incarceration within 24 months of study entry with most recent release within 60 days of study entry Must have designated individual who is generally aware of daily activities and who aggress to let study site know of any changes in subject’s circumstances when subject cannot |
SchizophreniaAges 20-55BMI must be less than 40 14 weeks 10 visits |
Must be clinically stable with only moderate symptoms Diagnosis of schizophrenia for at least 2 years |
SchizophreniaM-FAges 18+ No BMI 392+ Days 32 Visits |
Must have a caregiver/family member to ensure compliance with study Must be psychiatrically stable for at least 5 months before study entry Treatment with a maximum of 2 antipsychotics |
Bipolar DepressionM-FAges 18-75 BMI 18-40 6 weeks 8 visits |
Current depressive episode must be 4 weeks or less No history of non-response to 3 or more antidepressants for current episode |
BipolarInpatientAges 18-65 BMI 18-40 3 weeks inpatient |
Manic or mixed episode within 1 year of study entry No rapid cycling |
Alzheimer’sInpatientAges 50-89 No BMI 39+ weeks 14 Visits |
Must have diagnosis of probable Alzheimer’s disease Must have a caregiver to accompany on all visits |
Uncontrolled PainAges 18-80No BMI 52 weeks 20 visits |
No more than 135 mg per day of any opidoid medication for 2 weeks prior to study entry. |
